The largest database of trusted experimental protocols

Typhoon fla 7000 phosphorimager

Manufactured by GE Healthcare
Sourced in United Kingdom, United States, Sweden

The Typhoon FLA 7000 is a phosphorimager designed for the detection and analysis of radiolabeled samples. It utilizes a laser-based scanning system to capture high-resolution images of phosphor-based detection methods, such as autoradiography and phosphor screens. The instrument is capable of digitizing and quantifying the signals from these samples.

Automatically generated - may contain errors

67 protocols using typhoon fla 7000 phosphorimager

1

Western Blot Analysis of Whole Cell Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole cell extracts were prepared with the cell lysis buffer (10 mM Tris-HCl, pH 7.4, 1% SDS, and 1 mM Na3VO4) as described in our previous studies [57 (link), 58 (link)]. Protein extracts were subjected to Western Blot with the indicated primary antibodies, and probed with the AP-conjugated secondary antibody together with the enhanced chemifluorescence system as described in a previous reports [57 (link), 58 (link)]. The images were acquired by scanning with the PhosphorImager Typhoon FLA 7000 (GE, Pittsburgh, PA).
+ Open protocol
+ Expand
2

Radioactive Enzymatic Assays for Lipid Biosynthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enzymatic assays monitored either 1) the hGPT-mediated transfer of [14C]phospho-GlcNAc from [14C]UDP-GlcNAc to dolichyl phosphate (C55-Dol-P), forming [14C]Dol-PP-GlcNAc, or 2) the MraYAA-mediated transfer of [14C]phospho-MurNAc-pentapeptide from [14C]UDP-MurNAc-pentapeptide(DAP) ([14C]UM5A) to undecaprenyl phosphate (C55-P), forming [14C]Lipid I. A thin-layer chromatography (TLC)-based radiochemical assay 51 (link) was used, which was optimized for hGPT and MraYAA-catalyzed reactions for the experiments described below. All reactions were quenched by spotting a 2-μL aliquot on a silica gel 60 thin layer chromatography (TLC) plate (EMD Millipore). The products and substrates were separated by TLC using isopropanol/ammonium hydroxide/water (6:3:1; v/v/v) as the mobile phase. The spots corresponding to product and substrate were visualized via Phosphorimager (Typhoon FLA 7000, GE Healthcare LifeSciences). The spot intensity was quantified using the ImageQuant TL (GE Healthcare LifeSciences). All experiments were performed in triplicate.
+ Open protocol
+ Expand
3

Quantitative Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell extracts were prepared with the cell lysis buffer (10 mM Tris-HCl, pH 7.4, 1% SDS, and 1 mM Na3VO4) as described in our previous studies [54 (link)]. Protein extracts were subjected to western blot with the indicated primary antibodies, and probed with the AP-conjugated secondary antibody together with the enhanced chemifluorescence system as described in a previous report [54 (link)]. The images were acquired by scanning with the PhosphorImager Typhoon FLA 7000 (GE, Pittsburgh, PA). The densitometry analyses of the specific protein degradation were performed using software Image J (NIH, Bethesda, MD) to obtain the protein half-life, which is calculated using the formula described in a published article [55 (link)].
+ Open protocol
+ Expand
4

Radioactive Enzymatic Assays for Lipid Biosynthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enzymatic assays monitored either 1) the hGPT-mediated transfer of [14C]phospho-GlcNAc from [14C]UDP-GlcNAc to dolichyl phosphate (C55-Dol-P), forming [14C]Dol-PP-GlcNAc, or 2) the MraYAA-mediated transfer of [14C]phospho-MurNAc-pentapeptide from [14C]UDP-MurNAc-pentapeptide(DAP) ([14C]UM5A) to undecaprenyl phosphate (C55-P), forming [14C]Lipid I. A thin-layer chromatography (TLC)-based radiochemical assay 51 (link) was used, which was optimized for hGPT and MraYAA-catalyzed reactions for the experiments described below. All reactions were quenched by spotting a 2-μL aliquot on a silica gel 60 thin layer chromatography (TLC) plate (EMD Millipore). The products and substrates were separated by TLC using isopropanol/ammonium hydroxide/water (6:3:1; v/v/v) as the mobile phase. The spots corresponding to product and substrate were visualized via Phosphorimager (Typhoon FLA 7000, GE Healthcare LifeSciences). The spot intensity was quantified using the ImageQuant TL (GE Healthcare LifeSciences). All experiments were performed in triplicate.
+ Open protocol
+ Expand
5

Genomic DNA Extraction and Southern Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total genomic DNA was extracted according to the protocol of the QIAGEN Genomic DNA Handbook, using genomic-tip 100/G columns (a detailed protocol is provide in SI Materials and Methods). Two-dimensional gels were prepared and run as previously described (74 (link)). The DNA samples were digested by the enzyme indicated in the figures and then transferred to a Nylon Gene Screen Plus membrane (NEN) for Southern blotting analysis with specific probes against the loci. Primers used for amplification of the probes are available upon request. Signals were detected using a PhosphorImager Typhoon FLA 7000 (GE Healthcare) and quantified as previously described (75 (link)).
+ Open protocol
+ Expand
6

Genomic DNA Extraction and 2D Gel Electrophoresis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total genomic DNA was extracted according to the protocol of the QIAGEN Genomic DNA Handbook, using genomic-tip 100/G columns. 2D gel electrophoresis was carried out as originally described by Brewer and Fangman [78] (link). The DNA samples were digested with HindIII or SacI/ApaL1, for ARS305 and ARS607 detection respectively, and then blotted onto a Nylon Gene Screen Plus membrane (NEN). Membranes were probed with the BamHI-NcoI 3.0 kb fragment which spans ARS305 and was purified from plasmid A6C-110 (kindly provided by C. Newlon, uMDNJ, Newark, NJ), or probed with a 3.0 kb PCR product that spans ARS607. Signals were detected using a PhosphorImager Typhoon FLA 7000 (GE Healthcare).
+ Open protocol
+ Expand
7

Measuring p63α Protein Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
UROtsa(Nonsense) and UROtsa(shXIAP) were incubated with methionine–cysteine-free DMEM (Gibco-BRL, Grand Island, NY) containing 2% dialyzed fetal calf serum (Gibco-BRL, Grand Island, NY) in presence of MG132 (50 μM) for 1 hours. The cells were then incubated with 2% fetal bovine serum methionine–cysteine-free DMEM containing 35S-labeled methionine/cysteine (250 mCi per dish, Trans 35S-label; Perkin Elmer, Boston, MA) for the indicated time periods. The cells were extracted with lysis buffer (Cell Signaling, Beverly, MA) containing complete protein inhibitor mixture (Roche, Branchburg, NJ) on ice for 10 mins. Total lysate of 500 mg was incubated with anti-p63α antibody-conjugated agarose beads (R&D Systems, Minneapolis, MN) at 4°C overnight. The immunoprecipitated samples were washed with the cell lysis buffer five times, heated at 100°C for 5 min and then subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis analysis. The 35S-labeled p63α protein was detected with the PhosphorImager Typhoon FLA 7000 (GE, Pittsburgh, PA).
+ Open protocol
+ Expand
8

RNase III Cleavage Assay for RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols

In vitro-transcribed and purified RNAs were boiled in a thermocycler at 95°C for 10 min, cooled down to room temperature by sitting on a bench for 10 min, and kept on ice. Cleavage reactions were prepared by adding 40 ng of RNA; 1, 0.2, 0.04, 0.008, or 0 units of RNase III (Invitrogen); and water in the supplemented buffer to a total volume of 10 μL. After incubation for 5 min at 37°C, the reaction was stopped by adding an RNA loading buffer (0.025% bromophenol blue, 0.025% SDS, 0.025% xylene cyanol, 18 mM EDTA (pH 8.0), 93.64% formamide) on ice. The mixture then was boiled in a thermocycler at 95°C for 10 min, resolved on an 8% polyacrylamide gel (20 × 20 cm) containing 7 M urea at 300 V for 210 min, stained with SYBR Green II (Biozym), and visualized on a Phosphorimager (Typhoon FLA 7000, GE Healthcare). The Low Range ssRNA Ladder (New England Biolabs) was used as a marker. For the assays with the leader-repeat-spacer RNA for LrhCas9, the RNA was truncated within the leader and the spacer to avoid cleavage of irrelevant secondary structures formed internally within either domain.
+ Open protocol
+ Expand
9

RNase III Cleavage Assay for RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols

In vitro-transcribed and purified RNAs were boiled in a thermocycler at 95°C for 10 min, cooled down to room temperature by sitting on a bench for 10 min, and kept on ice. Cleavage reactions were prepared by adding 40 ng of RNA; 1, 0.2, 0.04, 0.008, or 0 units of RNase III (Invitrogen); and water in the supplemented buffer to a total volume of 10 μL. After incubation for 5 min at 37°C, the reaction was stopped by adding an RNA loading buffer (0.025% bromophenol blue, 0.025% SDS, 0.025% xylene cyanol, 18 mM EDTA (pH 8.0), 93.64% formamide) on ice. The mixture then was boiled in a thermocycler at 95°C for 10 min, resolved on an 8% polyacrylamide gel (20 × 20 cm) containing 7 M urea at 300 V for 210 min, stained with SYBR Green II (Biozym), and visualized on a Phosphorimager (Typhoon FLA 7000, GE Healthcare). The Low Range ssRNA Ladder (New England Biolabs) was used as a marker. For the assays with the leader-repeat-spacer RNA for LrhCas9, the RNA was truncated within the leader and the spacer to avoid cleavage of irrelevant secondary structures formed internally within either domain.
+ Open protocol
+ Expand
10

Quantification of Cas10-Csm crRNA Species

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total crRNAs were extracted from purified Cas10-Csm complexes using the TRIzol Reagent (Invitrogen, NY, USA) according to Hatoum-Aslan et al. (2014) (link). Extracted crRNAs were phosphorylated with T4 Polynucleotide Kinase (New England Biolabs, MA, USA), radiolabeled with γ-[32P]-ATP (PerkinElmer, MA, USA), and resolved on a 15% Urea PAGE gel. The gel was exposed for 10 min to a storage phosphor screen and visualized using a Typhoon FLA 7000 phosphor imager (GE Healthcare Bio-Sciences, PA, USA). For densitometric analysis, the ImageQuant software was used. Percent of intermediate crRNAs was determined with the following equation: ((intensity of intermediate crRNA signal (71 nt) ÷ sum of signal intensities for the dominant crRNA species (71 nt + 43 nt+37 nt+31 nt))×100%). The reported values represent an average of 3–5 replicates (±S.D.), as indicated in the Figure 2 legend and Figure 2—source data 1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!